NCT00856310View on ClinicalTrials.gov

A Single-Dose Study of the Safety and Tolerability of REGN475(SAR164877) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Healthy
Interventions
BIOLOGICAL

REGN475 (SAR164877)

Subcutaneous administration REGN475 (SAR164877)

Trial Locations (1)

Unknown

Altoona

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT00856310 - A Single-Dose Study of the Safety and Tolerability of REGN475(SAR164877) in Healthy Subjects | Biotech Hunter | Biotech Hunter